![The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001 – P578) | Bone Marrow Transplantation The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001 – P578) | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-022-01798-0/MediaObjects/41409_2022_1798_Figa_HTML.png)
The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001 – P578) | Bone Marrow Transplantation
![Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) - Radiotherapy and Oncology Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) - Radiotherapy and Oncology](https://www.thegreenjournal.com/cms/asset/9b6c8a6e-2da9-4579-82fe-37f8156ff48d/gr1.jpg)
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial) - Radiotherapy and Oncology
![Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future - Igor Mikaelian, Mark Cameron, Deidre A. Dalmas, Bradley E. Enerson, Raymond J. Gonzalez, Silvia Guionaud, Peter K. Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future - Igor Mikaelian, Mark Cameron, Deidre A. Dalmas, Bradley E. Enerson, Raymond J. Gonzalez, Silvia Guionaud, Peter K.](https://journals.sagepub.com/cms/10.1177/0192623314525686/asset/images/large/10.1177_0192623314525686-fig1.jpeg)